| Ms Julie A O'connor, LICSW | |
|
3445 Post Rd, C/o J. Arthur Memorial Trudeau Center, Warwick, RI 02886-7147 | |
| (401) 739-2700 | |
| (401) 921-5493 |
| Full Name | Ms Julie A O'connor |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 3445 Post Rd, Warwick, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013216126 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | CSW01301 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Julie A O'connor, LICSW 3445 Post Rd, C/o J. Arthur Memorial Trudeau Center, Warwick, RI 02886-7147 Ph: (401) 739-2700 | Ms Julie A O'connor, LICSW 3445 Post Rd, C/o J. Arthur Memorial Trudeau Center, Warwick, RI 02886-7147 Ph: (401) 739-2700 |
News Archive
InNexus Biotechnology Inc., a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, announces that it has, effective August 26, 2011, granted incentive stock options to purchase an aggregate of 1,068,683 common shares without par value in the capital of the Company to certain persons who are either a director, officer, employee or consultant of the Company.
QuantaLife, a new life science tool company developing the third generation of PCR, has received an NIH grant totaling ~$6 million over 5 years for the development of rapid, cost-effective technology for detecting methicillin-resistant Staphylococcus aureus (MRSA) infections. The grant, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health, will fund the project.
The work, which is published in the journal Occupational and Environmental Medicine, was carried out under the Fifth Framework Programme (FP5) Geoparkinson project, which aimed to investigate how genetic and environmental factors interact to cause Parkinson's disease and related conditions.
Personal Genome Diagnostics, Inc., a provider of advanced cancer genome analysis and testing services, today announced the launch of its ImmunoSelect-R service designed to identify mutant neoantigens and support development of immuno-oncology cancer therapies.
Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted oncolytic virus therapeutics, today announced that the European Medicines Agency (EMEA) has granted Orphan Drug Designation to Jennerex's product JX-594 for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. JX-594 is expected to enter a Phase 3 pivotal trial in the second half of 2010.
› Verified 2 days ago
Kathleen Blais, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 300 Toll Gate Rd Ste 300, Warwick, RI 02886 Phone: 401-467-0333 | |
Heather Ross, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2756 Post Rd, Warwick, RI 02886 Phone: 401-691-6000 Fax: 401-691-3398 | |
Ms. Suzanne Lee Monez, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 300 Centerville Rd Summit South, The Kent Center, Warwick, RI 02886 Phone: 401-738-1338 | |
Hermanett A.d Opele, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1035 Post Rd, Warwick, RI 02888 Phone: 401-785-0040 | |
Julie Lyons, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11 Cruise St, Warwick, RI 02888 Phone: 401-575-7640 | |
Ms. Jean M Bahrman, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 380 Jefferson Blvd, Suite D, Warwick, RI 02886 Phone: 401-864-2088 |